Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter
NCT01753232 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108
Last updated 2015-09-04
Summary
Low Density Lipoprotein (LDL)-apheresis refers to a procedure in which blood taken from a patient's vein is cleaned from pathogenic substances, e.g. cholesterol, outside the body and then given back to the patient. In the DALI (Direct Adsorption of Lipoproteins)-system whole blood is pumped over an adsorber containing beads that selectively bind LDL-cholesterol. The MONET (Membrane filtration Optimized Novel Extracorporeal Treatment)-system works with plasma which is cleaned by filtration. This study comprises the recording of safety and efficacy data from patients treated either with the DALI or MONET-system over a period of 2 years.
Conditions
- Hypercholesterolemia, Familial
- LIPOPROTEIN TYPES--Lp SYSTEM Lp(a) HYPERLIPOPROTEINEMIA
Interventions
- DEVICE
-
DALI-adsorber
Recording of treatment data. No extra interventional treatment
- DEVICE
-
MONET-Lipoprotein filter
Only treatment data recording. No extra interventional treatment
Sponsors & Collaborators
-
Fresenius Medical Care Deutschland GmbH
lead INDUSTRY
Principal Investigators
-
Rainer Heinzler, MD · Gemeinschaftspraxis Gysan, Heinzler, May, Hossmann
-
Franz Heigl, MD · Dres. Heigl, Hettich & Partner Medizinisches Versorgungszentrum
-
Frank Leistikow, MD · Nierenzentrum Mannheim
-
Frido Himmelsbach, MD · Apheresezentrum Ingelheim
-
Ralf Spitthöver, MD · Nephrologische Gemeinschaftspraxis Dialysezentrum/Lipidzentrum
-
Eberhard Roeseler, MD, Prof · Zentrum für Nieren,- Hochdruck und Stoffwechselerkrankungen Standort Heidering
-
Volker Schettler, MD · Nephrologisches Zentrum Goettingen
-
Gerd Schmitz, MD, Prof · University Regensburg Department Clinical Chemistry and Laboratory Medicine
-
Nadim Abduhl-Rahman, MD · Dialysezentrum Magdeburg-Stadtfeld
-
Jens Ringel, MD · Dialysezentrum Potsdam
-
Wolfgang Ramlow, MD · Apheresezentrum Rostock
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2014-12-31
- Completion
- 2015-08-31
Countries
- Germany
Study Locations
More Related Trials
-
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
NCT06094127 ·Status: ACTIVE_NOT_RECRUITING
-
Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis
NCT02133807 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients
NCT03344653 ·Status: COMPLETED ·Phase: NA
-
Over and Under/Aneugraft Pericardium Covered Stent Long Term Follow up Registry
NCT01307553 ·Status: UNKNOWN
-
Adapt Monorail Carotid Stent System: A Postmarket Clinical Follow-up Study
NCT01133327 ·Status: COMPLETED ·Phase: NA
-
Micronet Covered Stent in in Arterial Locations Beyond the Carotid Bifurcation - FLOW-Guard Study
NCT04461717 ·Status: UNKNOWN
-
Safety and Efficacy Evaluation of Orbital Atherectomy System in de Novo Calcified Lesions
NCT05417022 ·Status: RECRUITING
-
Randomized Comparison of Catheter-based Strategies for Interventional Access Site Closure During Transfemoral Transcatheter Aortic Valve Implantation
NCT04459208 ·Status: COMPLETED ·Phase: NA
-
GORE Flow Reversal System and GORE Embolic Filter Extension Study
NCT01343667 ·Status: COMPLETED ·Phase: NA
-
The Study to Evaluate the Safety and Efficacy of the Onyx Family
NCT06577896 ·Status: RECRUITING
-
GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN)
NCT00766493 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions
NCT07049120 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Safety and Efficacy of the Multilayer Stent
NCT01756911 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Thoracic Aortic Aneurysms and Chronic Dissections
NCT03738124 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Performance of the Neuroform Atlas™ Stent System
NCT04162483 ·Status: UNKNOWN
-
Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections
NCT02365467 ·Status: COMPLETED
-
Post-Approval Study for the MOSAIC® Bioprostheses
NCT01574625 ·Status: COMPLETED
-
Bare Metal Bifurcation Stent Clinical Trial in Humans
NCT00607321 ·Status: COMPLETED ·Phase: NA
-
MIDCAB Versus DES in Proximal LAD Lesions
NCT00299429 ·Status: COMPLETED ·Phase: NA
-
Carotid Filtration During Endovascular Aortic Valve Implantation
NCT01484249 ·Status: COMPLETED ·Phase: NA
-
ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis (2011-03)
NCT03752996 ·Status: COMPLETED ·Phase: NA
-
Bioflow-DAPT Study
NCT04137510 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure
NCT06075433 ·Status: RECRUITING
-
High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)
NCT07166731 ·Status: RECRUITING
-
Clinical Trial of T-wave™ Coronary Lithotripsy Catheter System
NCT05552131 ·Status: UNKNOWN ·Phase: NA